Cumberland Pharmaceuticals Reports Second Quarter 2021 Financial Results & Company Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Cumberland Pharmaceuticals (CPIX) Tops Q2 EPS by 15c
August 10, 2021 4:22 PM EDTCumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of $0.08, $0.15 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $8.57 million.
For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.
... More


